Brief: Sagimet Biosciences Offers 29.17 Million Shares Of Series A Common Stock - SEC Filing
28/04/2026 11:33
April 28 (Reuters) - SEC Filing: SAGIMET BIOSCIENCES INC - OFFERING 29.17 MILLION SHARES OF SERIES A COMMON STOCK - SEC FILING Source text: [ID:n0001104659-26-049662] Further company coverage: SGMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sagimet Biosciences
See all newsBrief: Sagimet Biosciences Announces Pricing Of $115.0 Million Underwritten Offering Of Series A Common Stock And Pre-Funded Warrants
Brief: Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Brief: Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial Of Denifanstat In Acne Toward Patient Enrollment In Q4 2026
Brief: Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage